Mar 26 |
Annexon files for $400M mixed shelf offering
|
Mar 26 |
Annexon Biosciences GAAP EPS of -$0.36 beats by $0.09
|
Mar 26 |
Annexon Reports Fourth Quarter and Year-End 2023 Financial Results and Key Anticipated Milestones
|
Mar 14 |
Why Annexon (ANNX) Might Surprise This Earnings Season
|
Mar 12 |
J.P. Morgan Predicts up to 140% Rally for These 2 ‘Strong Buy’ Stocks
|
Feb 27 |
Annexon Biosciences to Present at the TD Cowen 44th Annual Health Care Conference
|
Feb 21 |
Annexon to Host Virtual R&D Day on Guillain-Barré Syndrome, Focusing on its Serious Unmet Need and Annexon’s Novel Therapeutic Approach
|
Feb 20 |
Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)
|
Feb 13 |
Steven Cohen's Point72 Asset Management Acquires New Stake in Annexon Inc
|
Feb 10 |
Recent uptick might appease Annexon, Inc. (NASDAQ:ANNX) institutional owners after losing 18% over the past year
|